|1.||Patil, Bhimanagouda S: 2 articles (02/2013 - 01/2006)|
|2.||Sato, Ryuichiro: 2 articles (01/2013 - 07/2011)|
|3.||Kuttan, Girija: 2 articles (03/2012 - 10/2011)|
|4.||Pratheeshkumar, Poyil: 2 articles (03/2012 - 10/2011)|
|5.||Wada, Masahiro: 1 article (11/2015)|
|6.||Nakatani, Sachie: 1 article (11/2015)|
|7.||Kimira, Yoshifumi: 1 article (11/2015)|
|8.||Taniuchi, Yuri: 1 article (11/2015)|
|9.||Shimizu, Jun: 1 article (11/2015)|
|10.||Sekiguchi, Yuusuke: 1 article (11/2015)|
03/01/2012 - "Administration of nomilin inhibited tumor nodule formation in the lungs (68%) and markedly increased the survival rate of the metastatic tumor-bearing animals. "
10/15/2011 - "Nomilin significantly inhibited tumor directed capillary formation. "
01/01/1989 - "The number of mice with tumors was reduced from 100 to 72%, and the number of tumors per mouse was significantly decreased as a result of nomilin treatment. "
03/01/2012 - "Nomilin showed an inhibition of tumor cell invasion and activation of matrix metalloproteinases. "
10/15/2011 - "Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9."
01/01/2013 - "Nomilin as an anti-obesity and anti-hyperglycemic agent."
07/08/2011 - "Our results suggest a novel biological function of nomilin as an agent having anti-obesity and anti-hyperglycemic effects that are likely to be mediated through the activation of TGR5."
07/08/2011 - "Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet."
|3.||Neoplasm Metastasis (Metastasis)
|4.||Metabolic Diseases (Metabolic Disease)
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|4.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|5.||Plant Preparations (Preparation, Plant)
|8.||Transcription Factors (Transcription Factor)